Brooks, Allie, Michelle

Dr. Benjamin Toll is a licensed clinical psychologist, a professor of Public Health Sciences and Psychiatry, Co-Director of the Lung Cancer Screening Program, and Chief of Tobacco Cessation and Health Behaviors at the Hollings Cancer Center, and Director of the Tobacco Treatment Program at the Medical University of South Carolina. He specializes in treatment of tobacco use disorders, alcohol use disorders, and improvement of health behaviors.Dr. Toll has received grants from the National Institutes of Health, including the National Cancer Institute, and he is an author of over 110 peer-reviewed publications relating to nicotine and tobacco research, including several clinical practice guidelines and policy statements from US medical societies. He has served as an author for the American Association for Cancer Research (AACR) on a policy statement encouraging physicians to provide tobacco treatment for cancer patients,Dr. Toll's NCI funded research has focused on testing novel smoking cessation treatments and he has conducted numerous clinical trials in this regard. Many of his studies have investigated promotion of smoking cessation through novel message framing and motivational interventions, including those delivered via telephone and in person. Dr. Toll has tested several pharmacological and counseling interventions, and he also has expertise in the measurement of tobacco use and tobacco related syndromes (e.g. withdrawal)

Dr. John Kaczmar is a medical oncologist who specializes in caring for patients with cancers of the head and neck. He attended college at Cornell University, graduating Phi Beta Kappa. He then obtained his medical degree at Columbia University Medical School in New York City, where he served as president of his class. After medical school, he undertook a residency in internal medicine at the Hospital of the University of Pennsylvania. There, he served as a member of the resident steering committee and attained an additional certification in health care leadership in quality. Following this, he completed a fellowship in hematology and oncology at the Fox Chase Cancer Center in Philadelphia, before joining the Medical University of South Carolina in 2017. There are many challenges involved in treating cancers of the head and neck. Dr. Kaczmar's research interests are focused on overcoming these challenges through the use of the body's own immune system (immunotherapy) and targeted therapies aimed at fighting head and neck cancer growth. In addition to bringing cutting-edge treatment options to patients, he has an interest in working to improve the tolerability of proven treatments so as to maximize quality of life.